Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vivimed Labs Limited ( (IN:VIVIMEDLAB) ) has provided an announcement.
Vivimed Labs Limited has announced that Rare Asset Reconstruction Ltd. has acquired the company’s financial assets from the State Bank of India. This transfer includes all underlying security interests, rights, and obligations, allowing Rare ARC to recover dues from Vivimed Labs, impacting the company’s financial restructuring and stakeholder obligations.
More about Vivimed Labs Limited
Vivimed Labs Limited operates in the pharmaceutical industry, focusing on the development and production of specialty chemicals and pharmaceutical products. The company is known for its diverse range of healthcare and personal care products, catering to both domestic and international markets.
Current Market Cap: 406.3M INR
Find detailed analytics on VIVIMEDLAB stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “Losing the Console Race by Miles”: Microsoft Stock (NASDAQ:MSFT) Ticks Up as the Console Wars Gain a Bit of Clarity
- “…In 18 Months This is a $35,000 Truck” Tesla Stock (NASDAQ:TSLA) Surges With New Pricing Projections
- “Historic Union Busting”: Starbucks Stock (NASDAQ:SBUX) Slips as Strikes Gain Ground, Draw Congress Reps